Skip to content

4549.T

EIKEN CHEMICAL CO.,LTD.

プライム · 医薬品 · 医薬品 · JP

JPY 2,324.00
−0.21%
Ask drillr

Year over year

Reported trailing growth

Revenue
+3.4%
EBITDA
EBIT
-2.7%
EPS
+74.6%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
+0.7%
EBITDA
EPS
+1.6%

Three-year CAGR

Revenue
-1.1%
EBITDA
-17.1%
EBIT
-26.8%
Net income
-13.5%
EPS
-10.2%
Free cash flow

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026